Skip to content

Comparing Glycemic Outcomes Between a Family Medicine Led Modified NCD Clinic and a General Practice Clinic: A Retrospective Cohort Study

Comparing Glycemic Outcomes Between a Family Medicine Led Modified NCD Clinic and a General Practice Clinic: A Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20251117007
Enrollment
120
Registered
2025-11-17
Start date
2023-04-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus Type 2 patients NCD clinic, GP clinic, type 2 diabetes mellitus, HBA1C, FBS

Interventions

T2DM-Patients who were treated by modified NCDs clinic.,T2DM-Patients who were treated by general practice clinic.
Treatment,Treatment
Modified NCDs clinic ,General practice clinic (GP clinic)

Sponsors

Baramee Barameethavorn
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Patients aged 18 years and older who has been diagnosed with Type2 DM, recorded using the International Classification of Diseases and Related Health 10th revision codes E110-E119. 2)Received continuous care every 3 months for 1 year.

Exclusion criteria

Exclusion criteria: 1.Patients with severe cancer, advanced-stage cancer, or cancer currently under active treatment 2.Patients with frailty 3.Patients with end-stage chronic diseases, including chronic kidney disease, heart failure, severe chronic obstructive pulmonary disease (COPD), chronic lung disease, and dementia. 4.Pregnant women 5.Foreigners who cannot communicate in Thai 6.Patients with discontinuous follow-up during the study period or whose laboratory tests were not performed according to the scheduled intervals 7.Patients with incomplete data according to the case record form

Design outcomes

Primary

MeasureTime frame
HbA1C level at 1-3,4-6,7-9,10-12 months lab

Secondary

MeasureTime frame
Proportion of controlled HbA1C level at 1-3,4-6,7-9,10-12 months HbA1C levels were assessed against individualized glycemic targets according to the Thai DM Guideline 2023 (consider age and comorbidities), reports as percentage of patients achieving target control.

Countries

Thailand

Contacts

Public ContactBaramee Barameethavorn

Queen Savang Vadhana Memorial Hospital

baramee.ba@gmail.com038320200

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026